Clinical Trials Directory

Trials / Completed

CompletedNCT05141409

The COMBO CAD Study

The COMBO CAD Study: Characterization cOMparison Between twO CAD Systems

Status
Completed
Phase
Study type
Observational
Enrollment
500 (actual)
Sponsor
Istituto Clinico Humanitas · Academic / Other
Sex
All
Age
40 Years
Healthy volunteers
Not accepted

Summary

Implementation of clinical strategies based on optical diagnosis of \<5 mm colorectal polyps may lead to a substantial saving of economic and financial resources. Despite this, 84.2% of European endoscopists reported not to use such strategies - also named as leave-in situ and resect- and-discard - in their practice due to the fear of an incorrect optical diagnosis. Indeed, accuracy of optical diagnosis is operator-dependent, and values reported in the community setting are below the safety thresholds proposed for its incorporation in clinical practice. Artificial intelligence (AI) is being increasingly explored in different domains of medicine, particularly those entailing image analysis. As optical diagnosis involves subitaneous processing of multiple images, searching for specific visual clues, and recognizing well-defined visual patterns, AI systems has the potential to help endoscopists in distinguish neoplastic from non-neoplastic polyps, making the characterization process more reliable and objective. Computer-Aided-Diagnosis systems aiming at characterization are called CADx. Preliminary data on CADx showed a high feasibility and accuracy of AI for optical diagnosis of colorectal polyp, and initial experiences in clinical practice confirmed preliminary results. To assess the potential benefit and risk of AI-assisted optical diagnosis with standard colonoscopy, we exploited two new Computer-Aided-Diagnosis systems (CAD-EYE® Fujifilm Co., and GI-Genius® Medtronic) that provide the endoscopist with a real-time polyp characterization without the need of optical magnification.

Conditions

Interventions

TypeNameDescription
DEVICEArtificial IntelligenceArtificial Intelligence

Timeline

Start date
2022-01-26
Primary completion
2022-09-30
Completion
2022-09-30
First posted
2021-12-02
Last updated
2022-12-29

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05141409. Inclusion in this directory is not an endorsement.